Jeffrey Dierks, CHIEF COMMERCIAL OFFICER at Harmony Biosciences Holdings, Inc. (HRMY), sold 24,346 shares at $45.47 ($1.1M) on 2022-10-03, disclosed to the SEC on 2022-10-04.
Open-market sale of $1.1M HRMY by CHIEF COMMERCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.45 | 9,382 | $417K | 38.3% |
| 2 | $44.45 | 9,382 | $417K | 38.3% |
| 3 | $45.47 | 2,791 | $127K | 11.7% |
| 4 | $45.47 | 2,791 | $127K | 11.7% |
| Total | $44.68 avg | 24,346 | $1.1M | 100% |
| Filing → |
| HRMY | SELL | 2025-01-21 | $2.3M | — | Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |